102 related articles for article (PubMed ID: 9663459)
1. Endomorphin 1 and 2 have vasodepressor activity in the anesthetized mouse.
Champion HC; Zadina JE; Kastin AJ; Kadowitz PJ
Peptides; 1998; 19(5):925-9. PubMed ID: 9663459
[TBL] [Abstract][Full Text] [Related]
2. Endomorphin 1 and 2, endogenous mu-opioid agonists, decrease systemic arterial pressure in the rat.
Czapla MA; Champion HC; Zadina JE; Kastin AJ; Hackler L; Ge LJ; Kadowitz PJ
Life Sci; 1998; 62(13):PL175-9. PubMed ID: 9519803
[TBL] [Abstract][Full Text] [Related]
3. Endomorphin 1 and 2, the endogenous mu-opioid agonists, produce biphasic changes in systemic arterial pressure in the cat.
Champion HC; Bivalacqua TJ; Lambert DG; McWilliams SM; Zadina JE; Kastin AJ; Kadowitz PJ
Life Sci; 1998; 63(9):PL131-6. PubMed ID: 9740318
[TBL] [Abstract][Full Text] [Related]
4. The endogenous mu-opioid receptor agonists endomorphins 1 and 2 have novel hypotensive activity in the rabbit.
Champion HC; Zadina JE; Kastin AJ; Hackler L; Ge LJ; Kadowitz PJ
Biochem Biophys Res Commun; 1997 Jun; 235(3):567-70. PubMed ID: 9207197
[TBL] [Abstract][Full Text] [Related]
5. The endogenous mu-opioid agonists, endomorphin 1 and 2, have vasodilator activity in the hindquarters vascular bed of the rat.
Champion HC; Zadina JE; Kastin AJ; Kadowitz PJ
Life Sci; 1997; 61(26):PL 409-15. PubMed ID: 9416782
[TBL] [Abstract][Full Text] [Related]
6. Vasodepressor responses to [D-Ala2]-endomorphin 2 (TAPP) are mediated by an L-NAME-sensitive mechanism in the rat.
Champion HC; Kadowitz PJ
J Cardiovasc Pharmacol; 1999 Feb; 33(2):280-4. PubMed ID: 10028937
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide release mediates vasodilator responses to endomorphin 1 but not nociceptin/OFQ in the hindquarters vascular bed of the rat.
Champion HC; Bivalacqua TJ; Friedman DE; Zadina JE; Kastin AJ; Kadowitz PJ
Peptides; 1998; 19(9):1595-602. PubMed ID: 9864068
[TBL] [Abstract][Full Text] [Related]
8. Vasodilator responses to the endomorphin peptides, but not nociceptin/OFQ, are mediated by nitric oxide release.
Champion HC; Bivalacqua TJ; Zadina JE; Kastin AJ; Kadowitz PJ
Ann N Y Acad Sci; 1999; 897():165-72. PubMed ID: 10676445
[TBL] [Abstract][Full Text] [Related]
9. Endomorphin 1 and 2, endogenous ligands for the mu-opioid receptor, decrease cardiac output, and total peripheral resistance in the rat.
Champion HC; Zadina JE; Kastin AJ; Hackler L; Ge LJ; Kadowitz PJ
Peptides; 1997; 18(9):1393-7. PubMed ID: 9392842
[TBL] [Abstract][Full Text] [Related]
10. D-[Ala2]endomorphin 2 and endomorphin 2 have nitric oxide-dependent vasodilator activity in rats.
Champion HC; Kadowitz PJ
Am J Physiol; 1998 May; 274(5):H1690-7. PubMed ID: 9612381
[TBL] [Abstract][Full Text] [Related]
11. Endomorphin-1 and endomorphin-2, endogenous ligands for the mu-opioid receptor, inhibit electrical activity of rat rostral ventrolateral medulla neurons in vitro.
Chu XP; Xu NS; Li P; Wang JQ
Neuroscience; 1999; 93(2):681-6. PubMed ID: 10465452
[TBL] [Abstract][Full Text] [Related]
12. The antitussive effects of endomorphin-1 and endomorphin-2 in mice.
Kamei J; Morita K; Saitoh A; Nagase H
Eur J Pharmacol; 2003 Apr; 467(1-3):219-22. PubMed ID: 12706478
[TBL] [Abstract][Full Text] [Related]
13. [Effects of intracerebroventricular administration of endomorphin-1 on blood pressure in anesthetized rats].
Wu N; Huo XF; Chen Q; Yang DJ; Wang R
Yao Xue Xue Bao; 2001 Oct; 36(10):731-4. PubMed ID: 12579969
[TBL] [Abstract][Full Text] [Related]
14. Differential cardiorespiratory effects of endomorphin 1, endomorphin 2, DAMGO, and morphine.
Czapla MA; Gozal D; Alea OA; Beckerman RC; Zadina JE
Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):994-9. PubMed ID: 10988119
[TBL] [Abstract][Full Text] [Related]
15. Different motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouse.
Narita M; Ozaki S; Ioka M; Mizoguchi H; Nagase H; Tseng LF; Suzuki T
Neuroscience; 2001; 105(1):213-8. PubMed ID: 11483313
[TBL] [Abstract][Full Text] [Related]
16. Novel endomorphin-2 analogs with mu-opioid receptor antagonist activity.
Kruszynski R; Fichna J; do-Rego JC; Chung NN; Schiller PW; Kosson P; Costentin J; Janecka A
J Pept Res; 2005 Sep; 66(3):125-31. PubMed ID: 16083439
[TBL] [Abstract][Full Text] [Related]
17. Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat.
Champion HC; Kadowitz PJ
Life Sci; 1997; 60(16):PL 241-5. PubMed ID: 9096263
[TBL] [Abstract][Full Text] [Related]
18. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
19. Endomorphin-2 and endomorphin-1 promote the extracellular amount of accumbal dopamine via nonopioid and mu-opioid receptors, respectively.
Okutsu H; Watanabe S; Takahashi I; Aono Y; Saigusa T; Koshikawa N; Cools AR
Neuropsychopharmacology; 2006 Feb; 31(2):375-83. PubMed ID: 16034447
[TBL] [Abstract][Full Text] [Related]
20. Itch-associated response and antinociception induced by intracisternal endomorphins in mice.
Yamaguchi T; Kitagawa K; Kuraishi Y
Jpn J Pharmacol; 1998 Nov; 78(3):337-43. PubMed ID: 9869268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
